Cargando…
Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats
BACKGROUND: Insulin resistance is one of the most common and important pathological features of type 2 diabetes (T2D). Recently, insulin resistance is increasingly considered to be associated with systemic chronic inflammation. Elevated levels of tumor necrosis factor (TNF)-α and interleukin (IL)-1β...
Autores principales: | Sun, Xiaoya, Hao, Haojie, Han, Qingwang, Song, Xiaoyan, Liu, Jiejie, Dong, Liang, Han, Weidong, Mu, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667486/ https://www.ncbi.nlm.nih.gov/pubmed/29096724 http://dx.doi.org/10.1186/s13287-017-0668-1 |
Ejemplares similares
-
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
por: Yin, Yaqi, et al.
Publicado: (2018) -
Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012) -
Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice
por: Gao, Jieqing, et al.
Publicado: (2019) -
Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice
por: Li, Bing, et al.
Publicado: (2019) -
Mesenchymal stem cell therapy in type 2 diabetes mellitus
por: Zang, Li, et al.
Publicado: (2017)